The official topping of the Lvgu sugar drug production base is expected to benefit Alzheimer's patients worldwide

Shanghai, October 11, 2021/PRNewswire/ - On September 29, the main structure of the Green Valley Sugar Drug Production Base in Shanghai International Medical Park was officially completed and the main structure was fully capped.

The total investment of the project is 1.

Alzheimer's disease has become one of the diseases that seriously endanger the health and quality of life of the global elderly

Sugar science and sugar medicine have become an important part of life science research and new drug research and development in the 21st century.

China's original innovative drug, Ganlut Sodium Capsules, is one of the representatives of the successful development of sugar drugs, which has been approved for listing on November 2, 2019

As an innovative pharmaceutical company driven by R&D, Green Valley Pharmaceuticals always adheres to the holistic view and the "brain-gut axis" theory as the core, and uses sugar drugs as the means to explore treatments for humans to overcome chronic and complex diseases, and to develop the most anticipated drugs for patients.

At present, the international multi-center phase III clinical trial of Ganlut Sodium Capsules has been fully carried out.

references:

[1] Yin Jian, Ye Xinshan.

[2] Wu Ligen, Mao Wenjun.

Source: Green Valley Pharmaceutical